3D cell culture

AcroCyte Therapeutics, Inc. is a biotechnology company specializing in 3D cell culture technology. Its R³CE® (Rapid, Reproducible, Rare Cell 3D Expansion) platform enables scaffold-free expansion of rare cells such as circulating tumor cells (CTCs), biopsy-derived cells, and stem cells. The company offers an end-to-end platform from research tools to clinical diagnostic services, including its Onco-REAL™ clinical service for personalized treatment planning.

clinical laboratory servicesCTC culture from blood samplesdrug screeninghigh content imagingmanufacturingmulti-omics analysisorganoid culturescaffold-free cell expansion

Acrogenic Inc. is a biomedical engineering company developing a portfolio of innovative biomaterials and cutting-edge biomedical techniques targeting unmet medical needs in therapeutic cells, tissue engineering scaffolds, and novel copolymer drugs. It provides products and comprehensive solutions for 3D cell culturing, including extracellular matrix bioscaffolds, organoid culture kits, and circulating tumor cell culture kits.

biomedical engineeringdrug screeningin vitro and in vivo disease modelsorganoid development

Azture is a biotechnology company that merges living entities within engineered structures, pioneering human and animal primary cell culture devices into predictive model biotools. It provides both cells and engineered tool-boxes to generate disease responses in controlled environments, with extensive cell manufacture expertise across organ phenotypes, especially the liver. The company serves pharmaceutical companies, CROs, government, and academic institutions, and is a verified Veteran-owned small business.

3d Printingbioreactor trialsCAD Designcell developmentco-culturescompound exposure evaluationcryopreservation and cell thawinggrant application supportlow volume moldsmass productionmicrofluidics designprototypingtissue procurement

BioXtek is a regenerative medicine company that processes human placental tissues and birth byproducts into pharmaceutical-grade biologic therapies. It operates an 11,000 sqft cGMP/AATB facility that is FDA registered and inspected, and is AATB accredited. The company manufactures placental membrane patches and placental-derived exosome and stem cell products for regenerative therapeutics.

cGMP manufacturingcGTP processingcryopreservationextracellular matrix processinglyophilization

Genefront Inc is a California-based biotechnology company specializing in hiPSC-derived extracellular vesicles, advanced diagnostics, and scalable bioprocessing solutions. It develops extracellular vesicle-based therapeutics, in vitro diagnostic products, and bioprocessing systems for research and therapeutic development.

bioprocessingcold chain distributionextracellular vesicle engineeringformulation and packaginghiPSC technologyin vitro diagnosticslarge-scale GMP bioreactor productionprocess developmentpurification and chromatographytargeted EV delivery